https://www.selleckchem.com/products/repsox.html
Patients with high stromal scores had a lower overall survival rate (p = 0.00016), higher risk of recurrence (p less then 0.0001), and higher probability of chemotherapeutic resistance (p less then 0.0001) than those with low scores. We identified 16 tumor stroma biomarkers and generated a new prognosis indicator termed the biomarker stromal score (ranging from 0 to 16) based on their expression levels. Its addition to an age/tumor stage-based model significantly improved prognosis prediction accuracy. In conclusion, the tumor stromal sc
Mi piace
Commento
Condividi
